Position statement for reducing microbial risk when transporting COVID-19 vaccines in pop up, roving, and mobile models

Document first published:
Page updated:
Topic:
,
Publication type:

This position statement explains that when planning a vaccination session, the lead pharmacist and lead GP at the primary care network designated site should undertake an assessment to identify the risk factors associated with the transfer of vaccine, including punctured vials, and ensure that mitigations are put in place. The risk factors associated with the transfer of vials must also be identified, understood and mitigated by vaccinators. The statement also sets out risk reduction measures which must be in place.